Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Diurnal Group PLC

http://www.diurnal.co.uk/

Latest From Diurnal Group PLC

Diurnal Looking To Secure US Partner Soon For Alkindi

With its adrenal insufficiency therapy Alkindi getting established in Europe, the UK biotech is in partnering discussions in the US where approval is expected before the end of the year.

Commercial Companies

Deal Watch: Editas, BlueRock Ink Cross-Licensing Technology Collaboration

Combining Editas’ CRISPR gene-editing technology with BlueRock’s pluripotent stem cell capabilities, the companies hope to leverage each other to create novel gene therapies for cancer, neurological, cardiovascular and autoimmune diseases.

Deals Business Strategies

Start-Up Spruce Repurposes Lilly Drug For Genetic Adrenal Condition

Emerging Company Profile: Spruce and Neurocrine are both testing CRF-R1 antagonists for the orphan disease congenital adrenal hyperplasia, with Phase II data coming soon.

StartUps and SMEs Business Strategies

Chronocort European Phase III Study Failure “Surprises” Diurnal, All To Play For In US Studies

Diurnal has suffered a set-back on its road to approval and commercialization of Chronocort, but analysts still see hope for the product.

Clinical Trials Research & Development
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Diurnal Group PLC
  • Senior Management
  • Martin Whitaker, PhD, CEO
    Richard Bungay, CFO
    Richard Ross, MD, CSO
    Michael Withe, Commercial Dir.
  • Contact Info
  • Diurnal Group PLC
    Phone: 29 2068 2069
    Cardiff Medicentre, Heath Park
    Cardiff, CF14 4UJ
    UK
UsernamePublicRestriction

Register